Thayer White

Title: Thayer White: Innovator in Histo-Blood Group Research

Introduction

Thayer White is a notable inventor based in King County, WA (US). He has made significant contributions to the field of genetics, particularly in the study of histo-blood groups. With a total of 2 patents, his work has advanced the understanding of blood group identification and its implications in medical science.

Latest Patents

Thayer White's latest patents focus on ABO genotyping. The genes defining the ABO histo-blood groups are disclosed in these patents. Methods for identifying histo-blood group ABO status are provided, which include the use of DNA probes or size separation of DNA fragments unique to a blood group status. The inventions also disclose DNA constructs, recombinant methods for providing histo-blood glycosyltransferases, methods for tumor suppression, purified histo-blood group glycosyltransferases, and antibodies produced therefrom that bind to protein epitopes. Another significant patent involves purified histo-blood group A glycosyltransferase and antibodies related to it, further enhancing the methods for identifying blood group status.

Career Highlights

Thayer White is associated with The Biomembrane Institute, where he continues to innovate in his field. His research has implications for both clinical and therapeutic applications, particularly in understanding blood group genetics.

Collaborations

Thayer has collaborated with notable coworkers, including Fumi-ichiro Yamamoto and Sen-itiroh Hakomori. These collaborations have contributed to the advancement of research in histo-blood group studies.

Conclusion

Thayer White's contributions to the field of genetics, particularly in histo-blood group research, have been significant. His patents reflect a commitment to advancing medical science through innovative methods and technologies.